reparerx.com (RPTX) Company Sales Revenue

Risks for Repare Therapeutics (RPTX) are linked to environmental modernization costs and the implementation of "green chemistry." The company's trading revenue trend serves as a stability indicator, with the current value equal to 0.01. Positive drivers include the successes of the SNIPRx platform in identifying cancer therapy targets, as well as the absence of geopolitical barriers for scientific research in the US and Canada.

RPTX Repare Therapeutics Inc. Revenue and Sales Volume (07/04/2022 - 02/07/2026)

Comprehensive metric breakdowns and analytics for reparerx.com (RPTX)

- price and consensus price forecast:

Stock Price reparerx.com|RPTX - Price Target Chart

- market capitalization details:

Market Value Repare Therapeutics, Inc.|RPTX - Enterprise Value

- balance sheet net asset value indicators:

Book Value of One Share Repare Therapeutics|RPTX - Book Capitalization|Market-to-Book Ratio reparerx.com|RPTX - Cumulative Company Assets

- debt and solvency information:

Aggregate Debt to Capital Repare Therapeutics|RPTX - Long-Term Debt to Capital|Current Liabilities to Capital Repare Rx|RPTX - Company Aggregate Debts|Debt to Book Value Ratio Repare Therapeutics Inc|RPTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Repare Therapeutics|Intermediate Liquidity Ratio reparerx.com

- earnings and multiples data:

RPTX - Net Profit|Expected Net Income Repare Therapeutics|RPTX - P/E Multiple|Projected Price to Earnings Ratio Repare Therapeutics, Inc.|RPTX - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Repare Therapeutics, Inc.|RPTX - Operating profit EBITDA|Net earnings per share (EPS TTM) Repare Therapeutics|RPTX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months reparerx.com|RPTX - Net earnings per share growth this year|Expected net earnings per share growth next year Repare Therapeutics

- company sales and revenue statistics:

RPTX - Company Revenue|Company Future Revenue Repare Therapeutics|RPTX - P/S Multiple|Market Cap to Future Revenue Ratio Repare Rx

Summary company analysis:Repare Therapeutics Inc. RPTX

Finished products of Repare Therapeutics

Repare Therapeutics (RPTX) maintains a stable workforce in targeted therapy, ensuring continuity in drug development. This intellectual capital converts directly into commercial results, as reflected in the daily product sales revenue calculations. This metric allows for a comparison of current operational efficiency against historical data, identifying periods of cooling demand. Analyzing the company's aggregate sales levels helps investors promptly identify phases of business overheating or stagnation.

Competing companies